Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV

References

• Woo PC, Lau SK, Huang Y, Yuen KY. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med. 2009;234(10):1117–10. doi:10.3181/0903-MR-94.
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015:1282;1–23.
   Google Scholar
• Woo PC, Lau SK, Lam CS, Lau CC, Tsang AK, Lau JH, Bai KY, Teng JLL, Tsang CCC, Wang M, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86(7):3995–4008. doi:10.1128/JVI.06540-11.
   PubMed Web of Science ®Google Scholar
• Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. viruses. 2010;2(8):1804–20. doi:10.3390/v2081803.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wong G, Lu G, Yan J, Gao GF. MERS-CoV spike protein: targets for vaccines and therapeutics. Antiviral Res. 2016;133:165–77. doi:10.1016/j.antiviral.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251–4. doi:10.1038/nature12005.
   PubMed Web of Science ®Google Scholar
• Kindler E, Jónsdóttir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RAM, Drosten C, Müller MA. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio. 2013;4(1):10–1128. doi:10.1128/mBio.00611-12.
   Web of Science ®Google Scholar
• İnandıklıoğlu N, Akkoc T. Immune responses to SARS-CoV, MERS-CoV and SARS-CoV-2. In: Turksen K, editors. Cell biology and translational medicine, volume 9: stem cell-based therapeutic approaches in disease. Springer; 2020. p. 5–12.
   Google Scholar
• Zhou Y, Jiang S, Du L. Prospects for a MERS-CoV spike vaccine. Expert Rev Vaccines. 2018;17(8):677–86. doi:10.1080/14760584.2018.1506702.
   PubMed Web of Science ®Google Scholar
• Ramadan N, Shaib H. Middle East respiratory syndrome coronavirus (MERS-CoV): a review. Germs. 2019;9(1):35. doi:10.18683/germs.2019.1155.
   PubMedGoogle Scholar
• Mertz GJ, Wormser GP. Zoonoses: infectious diseases transmissible from animals to humans, fourth edition. Clin Infect Dis. 2016;63(1):148.2–9. doi:10.1093/cid/ciw234.
   Google Scholar
• World Health Organization. Middle east respiratory syndrome coronavirus (MERS-CoV)–update. Disease Outbreak News–MERS-CoV from, 05-05; 2014.
   Google Scholar
• Al-Amri SS, Abbas AT, Siddiq LA, Alghamdi A, Sanki MA, Al-Muhanna MK, Alhabbab RY, Azhar EI, Li X, Hashem AM. Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein. Sci Rep. 2017;7(1):44875. doi:10.1038/srep44875.
   PubMed Web of Science ®Google Scholar
• Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S. MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21(2):131–43. doi:10.1080/14728222.2017.1271415.
   PubMed Web of Science ®Google Scholar
• Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng CTK, Zhou Y, Du L, Jiang S. Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines. Vaccine. 2014;32(18):2100–8. doi:10.1016/j.vaccine.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Álvarez J, Honrubia JM, Fernández-Delgado R, Wang L, Castaño-Rodríguez C, Zúñiga S, Sola I, Enjuanes L. Genetically engineered live-attenuated Middle East respiratory syndrome coronavirus viruses confer full protection against lethal infection. MBio. 2021;12(2):10–1128. doi:10.1128/mBio.00103-21.
   Web of Science ®Google Scholar
• Choi JA, Goo J, Yang E, Jung DI, Lee S, Rho S, Jeong Y, Park Y-S, Park H, Moon Y-H. Cross-protection against MERS-CoV by prime-boost vaccination using viral spike DNA and protein. J Virol. 2020;94(24):10–1128. doi:10.1128/JVI.01176-20.
   Web of Science ®Google Scholar
• Cho H, Jang Y, Park KH, Choi H, Nowakowska A, Lee HJ, Kim M, Kang M-H, Kim J-H, Shin HY. Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2. NPJ Vaccines. 2021;6(1):37. doi:10.1038/s41541-021-00303-w.
   PubMed Web of Science ®Google Scholar
• Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Lees CR, Zhou T, Yassine HM, Kanekiyo M. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6(1):7712. doi:10.1038/ncomms8712.
   PubMed Web of Science ®Google Scholar
• Alharbi NK, Padron-Regalado E, Thompson CP, Kupke A, Wells D, Sloan MA, Grehan K, Temperton N, Lambe T, Warimwe G. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine. 2017;35(30):3780–8. doi:10.1016/j.vaccine.2017.05.032.
   PubMed Web of Science ®Google Scholar
• Muthumani K, Falzarano D, Reuschel EL, Kraynyak K, Ugen K, Kim P, Maslow J, Kim JJ, Sardesai NY, Kobinger G. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in non-human primates. Int J Infect Dis. 2016;45:23. doi:10.1016/j.ijid.2016.02.083.
   Web of Science ®Google Scholar
• Folegatti PM, Bittaye M, Flaxman A, Lopez FR, Bellamy D, Kupke A, Mair C, Makinson R, Sheridan J, Rohde C. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect Dis. 2020;20(7):816–26. doi:10.1016/S1473-3099(20)30160-2.
   PubMed Web of Science ®Google Scholar
• Koch T, Dahlke C, Fathi A, Kupke A, Krähling V, Okba NM, Halwe S, Rohde C, Eickmann M, Volz A. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect Dis. 2020;20(7):827–38. doi:10.1016/S1473-3099(20)30248-6.
   PubMed Web of Science ®Google Scholar
• Gary EN, Weiner DB. DNA vaccines: prime time is now. Curr Opin Immunol. 2020;65:21–7. doi:10.1016/j.coi.2020.01.006.
   PubMed Web of Science ®Google Scholar
• Liu MA. A comparison of plasmid DNA and mRNA as vaccine technologies. Nato Adv Sci Inst Se. 2019;7(2):37. doi:10.3390/vaccines7020037.
   Google Scholar
• Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Next‐generation vaccines: nanoparticle‐mediated dna and mrna delivery. Adv Healthcare Mater. 2021;10(8):2001812. doi:10.1002/adhm.202001812.
   Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update post COVID‐19 vaccines. Bioeng Transl Med. 2021 Sep;6(3):e10246. doi:10.1002/btm2.10246.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao C, Sabirsh A, Ye L, Wu X, Lu H, Liu J. A novel graphene quantum dot-based mRNA delivery platform. ChemistryOpen. 2021 Apr 7;10(7):666–71. doi:10.1002/open.202000200.
   PubMed Web of Science ®Google Scholar
• Wang Y, Song H, Liu C, Zhang Y, Kong Y, Tang J, Yang Y, Yu C. Confined growth of ZIF-8 in dendritic mesoporous organosilica nanoparticles as bioregulators for enhanced mRNA delivery in vivo. Natl Sci Rev. 2021 Aug;8(8):268. doi:10.1093/nsr/nwaa268.
   Web of Science ®Google Scholar
• Janjua TI, Cao Y, Yu C, Popat A. Clinical translation of silica nanoparticles. Nat Rev Mater. 2021 Dec;6(12):1072–4. doi:10.1038/s41578-021-00385-x.
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu Y, Chin JM, Phua KK. Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination. Eur J Pharm Biopharm. 2021 Jun 1;163:179–87. doi:10.1016/j.ejpb.2021.03.011.
   PubMed Web of Science ®Google Scholar
• Hom C, Lu J, Liong M, Luo H, Li Z, Zink JI, Tamanoi F. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small. 2010 June 6;6(11):1185–90. doi:10.1002/smll.200901966.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Quan G, Wu Q, Zhang X, Niu B, Wu B, Huang Y, Pan X, Wu C. Mesoporous silica nanoparticles for drug and gene delivery. Acta Pharm Sin B. 2018 Mar 1;8(2):165–77. doi:10.1016/j.apsb.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Ravinayagam V, Jermy BR. Fabricating hierarchical ZSM-5 to induct long chain antioxidant coenzyme Q10 for biomedical application. J Saudi Chem Soc. 2019;23(4):461–76. doi:10.1016/j.jscs.2018.09.001.
   Web of Science ®Google Scholar
• García-González CA, Fraile J, López-Periago A, Domingo C. Preparation of silane-coated TiO2 nanoparticles in supercritical CO2. J Colloid Interface Sci. 2009;338(2):491–9. doi:10.1016/j.jcis.2009.06.035.
   PubMed Web of Science ®Google Scholar
• Tai W, Zhang X, Yang Y, Zhu J, Du L. Advances in mRNA and other vaccines against MERS-CoV. Transl Res. 2022;242:20–37. doi:10.1016/j.trsl.2021.11.007.
   PubMed Web of Science ®Google Scholar
• Li Y, Li P, Li R, Xu Q. Intracellular antibody delivery mediated by lipids, polymers, and inorganic nanomaterials for therapeutic applications. Adv Ther. 2020;3(12):2000178. doi:10.1002/adtp.202000178.
   Google Scholar
• Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG 2nd, Nichols WW, Beare CM, Bagdon WJ, Nichols WW. Plasmid DNA vaccines: assay for integration into host genomic DNA. Dev Biol (Basel). 2000;104:33–43. doi:10.1159/000053993.
   PubMedGoogle Scholar
• Ledwith BJ, Manam S, Troilo PJ, Barnum AB, Pauley CJ, Griffiths TG II, Nichols WW, Beare CM, Bagdon WJ, Nichols WW. Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology. 2001;43(4–6):258–72. doi:10.1159/000053993.
   Web of Science ®Google Scholar
• Kim BM, Lee DS, Choi JH, Kim CY, Son M, Sun YS, Baek KH, Park KS, Sung YC, Kim WB. In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice. Arch Pharm Res. 2003;26(6):493–8. doi:10.1007/BF02976869.
   PubMed Web of Science ®Google Scholar
• Pilling AM, Harman RM, Jones SA, Mccormack NA, Lavender D, Haworth R. The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs. Toxicol Pathol. 2002;30(3):298–305. doi:10.1080/01926230252929864.
   PubMed Web of Science ®Google Scholar
• Bureau MF, Naimi S, Ibad RT, Seguin J, Georger C, Arnould E, Scherman D, Blanche F, Delaere P, Scherman D. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta Gene Struct Expression. 2004;1676(2):138–48. doi:10.1016/j.bbaexp.2003.11.005.
   PubMedGoogle Scholar
• Sheets RL, Stein J, Manetz TS, Duffy C, Nason M, Andrews C, Kong W-P, Nabel GJ, Gomez PL. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, severe acute respiratory syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts. Toxicol Sci. 2006;91(2):610–9. doi:10.1093/toxsci/kfj169.
   PubMed Web of Science ®Google Scholar
• Almansour I, Macadato NC, Alshammari T. Immunogenicity of multiple doses of pDNA vaccines against SARS-CoV-2. Pharmaceuticals. 2021;14(1):39. doi:10.3390/ph14010039.
   Web of Science ®Google Scholar
• Roper RL, Rehm KE. SARS vaccines: where are we? Expert Rev Vaccines. 2009;8(7):887–98. doi:10.1586/erv.09.43.
   PubMed Web of Science ®Google Scholar
• Almansour I, Boudellioua I. hCoronavirusesDB: an integrated bioinformatics resource for human coronaviruses. Database. 2022;2022:baac017. doi:10.1093/database/baac017.
   PubMedGoogle Scholar
• Almansour I, Alhagri M. MMRdb: measles, mumps, and rubella viruses database and analysis resource. Infect Genet Evol. 2019;75:103982. doi:10.1016/j.meegid.2019.103982.
   PubMed Web of Science ®Google Scholar
• Almansour I, Alhagri M, Alfares R, Alshehri M, Bakhashwain R, Maarouf A. IRAM: virus capsid database and analysis resource. Database. 2019;2019:baz079. doi:10.1093/database/baz079.
   PubMedGoogle Scholar